[A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization]. 2001

T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
Dept. of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University.

We report a patient with hepatocellular carcinoma (HCC) with portal vein thrombosis in the 1st branch who was treated by transcatheter arterial embolization (TAE) and survived more than 3 years. A 58-year old male was diagnosed as having unresectable massive type HCC in the area of S8 with portal vein thrombosis from the P8 branch to the right portal branch. He was treated by TAE via the anterior branch of right hepatic artery. One week later, localized hepatic infarction in the anterior segment was recognized. Five months later, the portal vein thrombosis had disappeared and become necrotic. After 3 years and 4 months, he died of a relapse of a gastric varix, but with no portal thrombosis and a well controlled intra-hepatic recurrence that was treated by repeated TAE. This case suggests that TAE might be effective for cases of HCC with portal vein thrombosis in the 1st branch, if the liver function and portal flow are suitable.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009360 Neoplastic Cells, Circulating Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. Circulating Neoplastic Cells,Embolic Tumor Cells,Embolism, Tumor,Neoplasm Circulating Cells,Tumor Cells, Embolic,Cells, Neoplasm Circulating,Circulating Cells, Neoplasm,Circulating Tumor Cells,Cell, Circulating Neoplastic,Cell, Circulating Tumor,Cell, Embolic Tumor,Cell, Neoplasm Circulating,Cells, Circulating Neoplastic,Cells, Circulating Tumor,Cells, Embolic Tumor,Circulating Neoplastic Cell,Circulating Tumor Cell,Embolic Tumor Cell,Embolisms, Tumor,Neoplasm Circulating Cell,Neoplastic Cell, Circulating,Tumor Cell, Circulating,Tumor Cell, Embolic,Tumor Cells, Circulating,Tumor Embolism,Tumor Embolisms
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D006499 Hepatic Artery A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum. Arteries, Hepatic,Artery, Hepatic,Hepatic Arteries
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017741 Survivors Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition as well as family members, significant others, or individuals surviving traumatic life events. Long-Term Survivors,Long Term Survivors,Long-Term Survivor,Survivor,Survivor, Long-Term,Survivors, Long-Term

Related Publications

T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
January 1995, Journal of gastroenterology and hepatology,
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
November 1987, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
January 1994, Journal of gastroenterology and hepatology,
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
October 2017, Asia-Pacific journal of clinical oncology,
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
May 2011, Annals of surgical oncology,
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
October 2021, World journal of surgical oncology,
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
June 2020, Hepatobiliary & pancreatic diseases international : HBPD INT,
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
November 2009, AJR. American journal of roentgenology,
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
February 1996, Presse medicale (Paris, France : 1983),
T Yamamoto, and H Nagano, and M Sakon, and A Miyamoto, and M Kondo, and I Arai, and O Morimoto, and K Dono, and K Umeshita, and S Nakamori, and T Murakami, and H Nakamura, and M Monden
March 2024, JAMA surgery,
Copied contents to your clipboard!